BioNTech falls on outlook, departure of co-founders
Source: SeekingAlpha
2026-03-10 07:48:05 ET
BioNTech ( BNTX ), the partner of Pfizer ( PFE ) for the Comirnaty COVID-19 vaccine, fell 18% in the premarket on Tuesday after its Q4 2025 financials, as its full-year outlook fell short of Street forecasts. ...
Read the full article on Seeking Alpha
For further details see:
BioNTech falls on outlook, departure of co-founders
Bristol-Myers Squibb Company
NASDAQ: BMY
BMY Trading
0.6% G/L:
$60.61 Last:
2,721,866 Volume:
$60.60 Open:
BMY Latest News
March 09, 2026 06:59:00 am
Bristol Myers Squibb Announces Positive Phase 3 Results from the SUCCESSOR-2 Study of Oral Mezigdomide in Relapsed or Refractory Multiple Myeloma
BMY Stock Data
$123,325,918,376
2,034,328,000
N/A
1394
N/A
Pharmaceuticals
Healthcare
US
Princeton
